NCT03493165|Unknown
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
1 other identifier
CTMS# 18-0020
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredApr 2018
Brief Summary
Single patient treatment with everolimus.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2018
Completed8 days until next milestone
First Posted
Study publicly available on registry
April 10, 2018
CompletedLast Updated
May 28, 2025
Status Verified
May 1, 2025
First QC Date
April 2, 2018
Last Update Submit
May 21, 2025
Conditions
Interventions
Sponsors & Collaborators
MeSH Terms
Interventions
Everolimus
Intervention Hierarchy (Ancestors)
SirolimusMacrolidesLactonesOrganic Chemicals
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2018
First Posted
April 10, 2018
Last Updated
May 28, 2025
Record last verified: 2025-05